Eldosin Capsule (Ergothioneine)

Adult dose

Adults: Administer 300 mg of erdosteine orally per dose, 2～3 times daily. When administered for acute respiratory conditions, do not use continuously for more than 10 days.

It is very important not to use this medication in certain patients. First, it should not be administered to patients who are allergic to this medication or its ingredients. Moreover, patients with liver cirrhosis or those deficient in cystathionine synthase should not take this medication. The metabolites of this medication may interfere with methionine metabolism in the body. Additionally, patients with peptic ulcers, severe renal impairment, or severe hepatic impairment should also avoid this medication. Patients with mild or moderate liver dysfunction should use this medication with caution, and should not exceed a daily dosage of 300 mg. Patients with diabetes or those on a low-calorie diet should be particularly cautious when using the syrup formulation. This product contains a dye called yellow No. 5, and patients with allergies or hypersensitivity to this ingredient should use it cautiously. Overdose may lead to symptoms such as sweating, dizziness, facial flushing, headache, cold symptoms, and respiratory difficulties, which have been reported as neurological and respiratory anomalies. Gastrointestinal symptoms may include taste disturbances, nausea, vomiting, diarrhea, abdominal pain, and heartburn. Skin reactions such as urticaria, erythema, and eczema may also occur. Additionally, various adverse reactions such as fatigue, indigestion, facial swelling, and itching have been reported, although their direct association with this medication is not clear. Caution is advised when taking this medication concurrently with cough medications, as it may hinder the expulsion of phlegm from the bronchi, thus increasing the risk of bronchial infections and bronchospasm. It is advisable for women who are pregnant or may become pregnant, as well as nursing mothers, to avoid using this medication. Although no particular toxicity has been found in animal experiments, its safety in humans has not been sufficiently established. This medication should be stored out of reach of children, and it is advisable to avoid transferring it to another container, as this may pose a risk of accidents and degrade the quality.

• Sweating
• dizziness
• flushing
• headache
• cold
• shortness of breath
• taste disorder
• nausea
• vomiting
• diarrhea

This medication should be stored in a tightly sealed container to protect it from air and moisture, preferably at room temperature between 1 to 30 degrees Celsius. Therefore, avoid overly hot or cold environments, and store it in a cool place away from direct sunlight.

Appearance

A hard capsule with a green upper part and a yellow lower part containing white to off-white crystalline powder.

Package unit

30 capsules/bottle, 300 capsules/bottle